Dr. Richard A. Vanetten, MD

Dr. Vanetten practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Vanetten's NPI, 1760536841, was assigned on January 23, 2007. Dr. Vanetten graduated from Stanford University School Of Medicine in 1984. Dr. Vanetten holds California license G128304.

Dr. Vanetten's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Vanetten's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vanetten practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Vanetten's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Vanetten is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Vanetten's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists acid reflux, chronic diabetes, neutropenia and sepsis among the conditions Dr. Vanetten treats.

CMS data shows 62 Medicare services from Dr. Vanetten across 2 procedure codes in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $6,966 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Dr. Vanetten in 2024. The largest group is 65 to 74, with 11 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vanetten's median patient age at 64, with 57% women.

In 2024, Dr. Vanetten wrote 155 Medicare Part D claims for 19 patients. 84% of them were for generic drugs. CMS names the drug for 137 of them, across 3 drugs with 11 or more claims each, at $603,310 in total drug cost. In 2023, CMS named 95 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Vanetten for performance year 2024, reported through an alternative payment model (APM). Dr. Vanetten accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vanetten as offering telehealth.

CMS Open Payments shows 14 general payments to Dr. Vanetten from 6 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 99% of the total. Pfizer Inc. paid the most, $19,250. It also lists 1 research payment totaling $5,528 in 2018.

Dr. Vanetten graduated from Stanford University School Of Medicine in 1984.

Dr. Vanetten is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.